Cannabidiol Oil Market Size, Share and Growth Outlook, 2026

Cannabidiol Oil Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Cannabidiol Oil Market size is forecast to increase from $15.51 Billion in 2026 to $44.87 Billion in 2034 at a CAGR of 14.2% between 2026 and 2034.

The Cannabidiol Oil market report provides detailed analysis and outlook of Cannabidiol Oil segments including By Source Type (Hemp-Derived CBD Oil, Marijuana-Derived CBD Oil), By Product Category (Full-Spectrum CBD Oil, Broad-Spectrum CBD Oil, CBD Isolate Oil), By Application (Pharmaceuticals & Medical Treatment, Personal Care & Cosmetics, Food & Beverages, Nutraceuticals & Wellness Supplements, Pet Care), By Distribution Channel (Hospital & Specialty Pharmacies, Retail Stores & Supermarkets, Online, Medical Dispensaries) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Cannabidiol (CBD) Oil Industry Overview

Expanding Medical Cannabis Markets Supporting CBD Industry Growth

The cannabidiol (CBD) oil industry continues to evolve alongside the expanding global medical cannabis sector. A significant development has been the relaunch of the Tweed brand in the German medical cannabis market by Canopy Growth Corporation following its acquisition of MTL Cannabis Corp. This strategic expansion introduces a broader portfolio of cannabis strains designed to address increasing demand within Germany's regulated medical cannabis sector. The move reflects the growing importance of Europe as a key market for cannabinoid-based products and highlights the increasing commercialization of medical cannabis therapies. As regulatory frameworks mature and patient access expands, manufacturers are investing in product diversification, quality assurance programs, and distribution capabilities to strengthen their position in rapidly developing international markets. The continued growth of medical cannabis infrastructure is creating new opportunities for CBD oil products across pharmaceutical, wellness, and therapeutic applications.

Regulatory Standards Strengthening CBD Product Development

Regulatory developments are playing an increasingly important role in shaping the future of the cannabidiol oil industry. The establishment of a defined safe daily consumption level for cannabidiol by the European Food Safety Authority represents a significant milestone for manufacturers operating within the European Union. Although the recommended threshold is relatively conservative, it provides an important scientific and regulatory benchmark for product formulation, labeling, safety assessment, and compliance strategies. Clear regulatory guidance helps manufacturers develop products that align with evolving safety expectations while providing consumers and healthcare professionals with greater confidence regarding CBD use. As governments and regulatory agencies continue to refine cannabinoid-related policies, standardized safety frameworks are expected to contribute to greater market transparency, improved product consistency, and stronger consumer trust across the CBD sector.

Neuroinflammation Research Expanding Therapeutic Interest in CBD

Scientific research continues to uncover potential therapeutic applications for cannabidiol beyond traditional wellness categories. A recent study published in eNeuro and reported by the Society for Neuroscience demonstrated that inhaled CBD reduced neuroinflammation in mouse models of Alzheimer's disease. The findings suggest that cannabidiol may help regulate inflammatory responses within the brain by modulating immune system activity, supporting interest in its potential as a multi-target therapeutic agent. This research is contributing to a growing body of evidence examining the role of cannabinoids in neurological disorders, neurodegenerative diseases, and inflammatory conditions. The ability of CBD to influence multiple biological pathways simultaneously is attracting increasing attention from researchers exploring novel treatment approaches for complex chronic diseases. As preclinical and clinical investigations continue to expand, neuroinflammation-focused research is becoming an important driver of innovation within the broader cannabidiol oil industry.

Cannabidiol Oil Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Cannabidiol Oil market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Charlotte's Web Holdings, Inc., CV Sciences, Inc. (PlusCBD), Medterra CBD, Balance优 (Balanceme / Balanced Health Botanicals), Green Roads (The Vitamin Shoppe), Kazmira LLC, Elixinol Wellness Limited, Isodiol International Inc., Endoca BV, CBDistillery. The Cannabidiol Oil market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Cannabidiol Oil industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Cannabidiol Oil Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Cannabidiol Oil companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Cannabidiol Oil markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Cannabidiol Oil Market Competitive Benchmarking and Company Analysis

Leading companies in Cannabidiol Oil industry include- Charlotte's Web Holdings, Inc., CV Sciences, Inc. (PlusCBD), Medterra CBD, Balance优 (Balanceme / Balanced Health Botanicals), Green Roads (The Vitamin Shoppe), Kazmira LLC, Elixinol Wellness Limited, Isodiol International Inc., Endoca BV, CBDistillery. The Cannabidiol Oil market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Cannabidiol Oil Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Cannabidiol Oil market remains one of the strongest-performing segments in the country.
The US Cannabidiol Oil Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Cannabidiol Oil market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Cannabidiol Oil industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Cannabidiol Oil markets

Canada's strong Cannabidiol Oil sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Cannabidiol Oil market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Cannabidiol Oil Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Cannabidiol Oil market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Cannabidiol Oil population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Cannabidiol Oil industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Cannabidiol Oil market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Cannabidiol Oil sales through 2034

France Cannabidiol Oil companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Cannabidiol Oil Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Cannabidiol Oil distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Cannabidiol Oil Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Cannabidiol Oil market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Cannabidiol Oil industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Cannabidiol Oil industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Cannabidiol Oil Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Cannabidiol Oil market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Cannabidiol Oil market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Cannabidiol Oil Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Cannabidiol Oil Market Segmentation

By Source Type
Hemp-Derived CBD Oil
Marijuana-Derived CBD Oil
By Product Category
Full-Spectrum CBD Oil
Broad-Spectrum CBD Oil
CBD Isolate Oil
By Application
Pharmaceuticals & Medical Treatment
Personal Care & Cosmetics
Food & Beverages
Nutraceuticals & Wellness Supplements
Pet Care
By Distribution Channel
Hospital & Specialty Pharmacies
Retail Stores & Supermarkets
Online
Medical Dispensaries

Top Companies in Cannabidiol Oil Industry

Charlotte's Web Holdings, Inc.
CV Sciences, Inc. (PlusCBD)
Medterra CBD
Balance优 (Balanceme / Balanced Health Botanicals)
Green Roads (The Vitamin Shoppe)
Kazmira LLC
Elixinol Wellness Limited
Isodiol International Inc.
Endoca BV
CBDistillery

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025